Plasma ceruloplasmin and fibrinogen during enzyme therapy of mastitis in dairy cows

Acta Veterinaria Brno

Volumn 75, Issue 2, 2006, Pages 241-246

  Bakes J ^a,c   Illek, J ^b  

^a Hospital Pharmacy Pod ipská Hospital and Health Centre   (Czech Republic)

^b UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

^c Hospital Pharmacy   (Czech Republic)

Author keywords

Bromelain; Cefotaxime; Chymotrypsin; Papain

Indexed keywords

BOS TAURUS;

EID: 33745910868     PISSN: 00017213     EISSN: 00017213     Source Type: Journal    
DOI: 10.2754/avb200675020241     Document Type: Article

References (16)

1. DESSER L, HERBACEK I, ZAVADOVA E, MOHRT 1999: Polyenzyme preparations interrupt the autocrine loop of TGF-beta production in melanoma cells by conversing alpha2Macroglobulin (a2M) into the fast-form which binds TGF-beta irreversible. Eur J Cancer 35: 375 p.
2. DESSER L, HOLOMANOVA D, ZAVADOVA E, PAVELKA K, MOHR T, HERBACEK I 2001: Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood. Cancer Chemoth Pharm 47: 10-15
3. DESSER L, REHBERGER A, KOKRON E, PAUKOVITS W 1993: Cytokine synthesis in human peripheral blood mononuclear cells after oral administration of polyenzyme preparations. Oncology 50: 403-407
4. HENRY R, CANNON D, WINKELMAN J 1974: Clinical Chemistry, Principles and Technics. Harper & Row, New York,
5. KASSEROLLER R, WENNING H2003: Efficacy and tolerability of proteolytic enzymes as an anti-inflammatory agent in lymphoedema after axillary dissection due to mammary cancer. Eur J Lymphol 10: 8-26
6. KOVAC G, VARGOVA M, POPELKOVA M, NOVOTNY J 2005: Acute Phase Proteins in Cattle. Achievements and Prospects of Ruminants Medicine. Pulawy, pp. 48-53
7. LUERTI M, VIGNALI M 1978: Influence of bromelain on penetration of antibiotics in uterus, salpinx and ovary. Drugs Exp Clin Res 4: 45-48
8. MASOPUST J 1998: Klinická biochemie: požadová ní a hodnocení biochemických vyšetření . II. část. Karolinum, Praha, 345 p.
9. NEUBAUER R 1961: A plant protease for potentiation of and possible replacement of antibiotics. Exp Med Surg 19: 143-160
10. NOUZA K, OLEJAR T, NOUZA M1999: Proteázy v regulaci a modulaci imunity. Klinická imunologia 3: 27-28
11. OLEJAR T, NOUZA K 1998: Trombin a trypsin regulují bunuěčnou odpověd' aktivací specifických receptorů. Zpravodaj klinické farmakologie a farmacie 4: 19-22
12. SALAMBERIDZE L, KARTVELISHVILI, E, LORTKIPANIDZE M 2002: Effect of current administration of Taureodon and Wobenzym in Rheumatoid Arthritis. Int J Immunorehab 1: 110-111
13. SUCHICH G, LOGINOVA N, FAIZULLIN L, ZDANOV A, MALININA E, BOZEDOMOV V 1997: The use of Wobenzym to facilitate interferon synthesis in the treatment of chronic urogenital chlamydiosis. International Journal on Immunotherapy 13: 131-133
14. TINOZZI S, VENEGONI A 1978: Effect of bromelain on serum and tissue levels of amoxicillin. Drugs Exp Clin Res 4: 39-44
15. WALD M, OLEJAR T, SEBKOVA V, ZADINOVA M, BOUBELIK M, POUCKOVA P 2001: Mixture of trypsin, chymotrypsin and papain reduces formation of metastases and extends survival time of C57Bl6 mice with syngeneic melanoma B16. Cancer Chemother Pharmacol 47 Suppl: S16-S22
16. XIANG G, SCHINZEL R, SIMM A, MUNCH G, SEBEKOVA K, KASPER M, NIWA T, SCHMITZ C, HEIDLAND A 2001: Advanced glycation end products (AGEs)-induced expression of TGF-beta 1 is suppressed by a protease in the tubule cell line LLC-PK1. Nephrol Dial Transplant 16: 1562-1569